<DOC>
	<DOC>NCT01563237</DOC>
	<brief_summary>To assess the safety and performance of the MIDI Arrow in patients suffering from glaucoma that is inadequately controlled on maximum tolerated medical therapy with intraocular pressure ≥ 18 mm Hg and ≤ 40 mm Hg</brief_summary>
	<brief_title>Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<criteria>1. Male or female patient, age 18 to 85 years, inclusive 2. Patient has primary open angle glaucoma that is inadequately controlled on tolerated medical therapy with intraocular pressure greater than or equal to 18 mm Hg and less than or equal to 40 mm Hg 3. Patient must have signed and dated the Informed Consent form 1. Unwilling or unable to give informed consent or unable to return for scheduled protocol visits. 2. Pregnant or nursing women. 3. No light perception. 4. Active iris neovascularization or active proliferative retinopathy. 5. Iridocorneal endothelial syndrome. 6. Epithelial or fibrous downgrowth. 7. Pseudoexfoliative glaucoma 8. Aphakia. 9. Vitreous in anterior chamber for which a vitrectomy is anticipated. 10. Corneal disease 11. Acute, chronic or recurrent uveitis. 12. Severe posterior blepharitis. 13. Unwilling to discontinue contact lens use after surgery. 14. Previous ophthalmic surgery, excluding phacoemulsification (cataract) surgery or corneal refractive surgery. 15. Prior cataract surgery involving a conjunctival incision 16. Need for glaucoma surgery combined with other ocular procedures except for cataract surgery or anticipated need for additional ocular surgery during the investigational period. 17. Less than 0.1 (20/200) visual acuity in the nontest eye. 18. Infectious conjunctivitis, a narrowangle glaucoma, endophthalmitis, orbital cellulitis one, infection, severe dry eye, severe myopia, conjunctivitis fine.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>